ask="0.760"
ask_size="6000"
average_daily_volume="119295"
bid="0.720"
bid_size="3000"
book_value="0.725"
change="-0.402"
change_from_200_day_moving_average="-0.698"
change_from_50_day_moving_average="-0.557"
change_from_52_week_high="-1.322"
change_From_52_week_low="0.028"
change_in_percent="-37.222%"
close="0.678"
dividend_pay_date="11/8/2012"
dividend_per_share="0.000"
dividend_yield="0.000"
earnings_per_share="-0.810"
ebitda="-30.60M"
eps_estimate_current_year="-0.850"
eps_estimate_next_quarter="-0.200"
eps_estimate_next_year="-0.860"
ex_dividend_date="11/9/2012"
float_shares="30554000"
high="0.740"
high_52_weeks="2.000"
last_trade_date="2/14/2017"
last_trade_price="0.678"
last_trade_size="1604"
last_trade_time="4:00pm"
low="0.650"
low_52_weeks="0.650"
market_capitalization="26.20M"
moving_average_200_day="1.376"
moving_average_50_day="1.235"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.170"
open="0.670"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-50.742%"
percent_change_from_50_day_moving_average="-45.114%"
percent_change_from_52_week_high="-66.100%"
percent_change_from_52_week_low="+4.308%"
previous_close="1.080"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.490"
price_per_sales="4.259"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="1.370"
stock_exchange="NMS"
symbol="AVIR"
volume="1958799"
weeks_range_52="0.650 - 2.000"
